<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><description>【国内外药讯，医药市场，医药数据分享】</description><managingEditor> (hellodword)</managingEditor><pubDate>Tue, 30 Mar 2021 13:26:36 +0800</pubDate><image><url>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</url><title>药物简讯 | wechat-feeds</title><link>http://MzI4OTIzMzcwMw.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>2020年信立泰净利润仅386万元，拿什么撑起400亿市值？</title><link>https://mp.weixin.qq.com/s/xbCegEr2RyfUeWy07TF1rg</link><description></description><content:encoded><![CDATA[2020年信立泰净利润仅386万元，拿什么撑起400亿市值？]]></content:encoded><pubDate>Tue, 30 Mar 2021 12:53:38 +0800</pubDate></item><item><title>复星医药2020年营收首破300亿，过亿单品39个！</title><link>https://mp.weixin.qq.com/s/iFuF-0KQUn5cUxMLgnyJqg</link><description></description><content:encoded><![CDATA[复星医药2020年营收首破300亿，过亿单品39个！]]></content:encoded><pubDate>Tue, 30 Mar 2021 12:53:38 +0800</pubDate></item><item><title>开拓市值大涨：披露普克鲁胺治疗新冠商业化在即</title><link>https://mp.weixin.qq.com/s/HXLzpXpwpvYn_WGHkURq0Q</link><description></description><content:encoded><![CDATA[开拓市值大涨：披露普克鲁胺治疗新冠商业化在即]]></content:encoded><pubDate>Sun, 28 Mar 2021 17:37:15 +0800</pubDate></item><item><title>重磅！新华制药和中国药科大学签订联合研究合作协议</title><link>https://mp.weixin.qq.com/s/u3VLAUB32Z0ws-F-atesyQ</link><description></description><content:encoded><![CDATA[重磅！新华制药和中国药科大学签订联合研究合作协议]]></content:encoded><pubDate>Fri, 26 Mar 2021 17:13:47 +0800</pubDate></item><item><title>改良型新药！汉都医药拟完成近3亿元融资和股权转让</title><link>https://mp.weixin.qq.com/s/RSPS7d8PpOpq1oKhqammMA</link><description></description><content:encoded><![CDATA[改良型新药！汉都医药拟完成近3亿元融资和股权转让]]></content:encoded><pubDate>Fri, 26 Mar 2021 10:50:11 +0800</pubDate></item><item><title>CDMO火热！汉腾生物获5900万元新一轮投资</title><link>https://mp.weixin.qq.com/s/63SwJhZKxNgeQqUg22osQw</link><description></description><content:encoded><![CDATA[CDMO火热！汉腾生物获5900万元新一轮投资]]></content:encoded><pubDate>Fri, 26 Mar 2021 10:50:11 +0800</pubDate></item><item><title>重磅！科伦博泰RET抑制剂海外达成授权</title><link>https://mp.weixin.qq.com/s/MWUe7MStjFExZh60ApkwDA</link><description></description><content:encoded><![CDATA[重磅！科伦博泰RET抑制剂海外达成授权]]></content:encoded><pubDate>Thu, 25 Mar 2021 17:00:45 +0800</pubDate></item><item><title>纽脉医疗完成超亿美元C轮融资，淡马锡领投</title><link>https://mp.weixin.qq.com/s/qaDgHrYsm8_SHsatqQPq1g</link><description></description><content:encoded><![CDATA[纽脉医疗完成超亿美元C轮融资，淡马锡领投]]></content:encoded><pubDate>Thu, 25 Mar 2021 17:00:45 +0800</pubDate></item><item><title>腾盛博药完成1.55亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/h47EeDlo7DOrfetTSR8GVA</link><description></description><content:encoded><![CDATA[腾盛博药完成1.55亿美元C轮融资]]></content:encoded><pubDate>Tue, 23 Mar 2021 20:38:50 +0800</pubDate></item><item><title>岸迈生物完成1.2亿美元C轮融资</title><link>https://mp.weixin.qq.com/s/-rhxk_UFLyn1UMMH6oAPKg</link><description></description><content:encoded><![CDATA[岸迈生物完成1.2亿美元C轮融资]]></content:encoded><pubDate>Tue, 23 Mar 2021 20:38:50 +0800</pubDate></item><item><title>估值超50亿元！科伦博泰完成超5亿元豪华Pre-IPO轮融资</title><link>https://mp.weixin.qq.com/s/y95GgbdNkkXm_gQ-oMuT7A</link><description></description><content:encoded><![CDATA[估值超50亿元！科伦博泰完成超5亿元豪华Pre-IPO轮融资]]></content:encoded><pubDate>Mon, 22 Mar 2021 20:36:12 +0800</pubDate></item><item><title>重磅！丽珠集团7.24亿元收购天津同仁堂40%股权</title><link>https://mp.weixin.qq.com/s/ExDTe5jE8Bxzu3yKatYL0Q</link><description></description><content:encoded><![CDATA[重磅！丽珠集团7.24亿元收购天津同仁堂40%股权]]></content:encoded><pubDate>Mon, 22 Mar 2021 20:36:12 +0800</pubDate></item><item><title>开拓药业的新出路：市值较年前翻3倍</title><link>https://mp.weixin.qq.com/s/jVqZjmlNbs-iLwGXxaG9Zg</link><description></description><content:encoded><![CDATA[开拓药业的新出路：市值较年前翻3倍]]></content:encoded><pubDate>Sun, 21 Mar 2021 19:00:15 +0800</pubDate></item><item><title>近4000亿市值！药明生物连续并购生物药CDMO工厂，产能欲突破30万升</title><link>https://mp.weixin.qq.com/s/AOi2h5fbsLYBrzaZUL_CsQ</link><description></description><content:encoded><![CDATA[近4000亿市值！药明生物连续并购生物药CDMO工厂，产能欲突破30万升]]></content:encoded><pubDate>Thu, 18 Mar 2021 10:31:02 +0800</pubDate></item><item><title>嘉和生物CD20xCD3双抗提交澳大利亚临床申请</title><link>https://mp.weixin.qq.com/s/kpFnHpC-sPeAuoam6ybhmg</link><description></description><content:encoded><![CDATA[嘉和生物CD20xCD3双抗提交澳大利亚临床申请]]></content:encoded><pubDate>Thu, 18 Mar 2021 10:31:02 +0800</pubDate></item><item><title>白云山分拆广州医药到港股主板上市获得受理！</title><link>https://mp.weixin.qq.com/s/ppPR46CAc_VyWFtcwlcI4Q</link><description></description><content:encoded><![CDATA[白云山分拆广州医药到港股主板上市获得受理！]]></content:encoded><pubDate>Thu, 18 Mar 2021 10:31:02 +0800</pubDate></item><item><title>贝达药业引进的EGFR/c-Met双抗获批临床</title><link>https://mp.weixin.qq.com/s/AbZjgRFlwlsZSYpa5g_N0w</link><description></description><content:encoded><![CDATA[贝达药业引进的EGFR/c-Met双抗获批临床]]></content:encoded><pubDate>Wed, 17 Mar 2021 13:12:41 +0800</pubDate></item><item><title>又有6款创新药拟纳入突破性治疗药物程序！</title><link>https://mp.weixin.qq.com/s/8l56EU4UE8BSLIu4CchwUQ</link><description></description><content:encoded><![CDATA[又有6款创新药拟纳入突破性治疗药物程序！]]></content:encoded><pubDate>Wed, 17 Mar 2021 13:12:41 +0800</pubDate></item><item><title>这3款新药拟获得优先审评审批资格！</title><link>https://mp.weixin.qq.com/s/yv9ntR0hBonZMY1hiEB37g</link><description></description><content:encoded><![CDATA[这3款新药拟获得优先审评审批资格！]]></content:encoded><pubDate>Wed, 17 Mar 2021 13:12:41 +0800</pubDate></item><item><title>药明生物宣布收购辉瑞中国生物药原液和制剂生产基地</title><link>https://mp.weixin.qq.com/s/3SXsVLlNWtck-7zeiTIwww</link><description></description><content:encoded><![CDATA[药明生物宣布收购辉瑞中国生物药原液和制剂生产基地]]></content:encoded><pubDate>Wed, 17 Mar 2021 13:12:41 +0800</pubDate></item></channel></rss>